Clinical Trials

779 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT03671330 2025-10-31

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

327 enrolled

Breast Neoplasms

NCT03822468 2025-10-16

AMALEE

376 enrolled 17 charts

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT05549505 2025-08-29

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

152 enrolled 16 charts

Breast Neoplasms

NCT03099174 2025-06-24

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Phase 1 Completed

133 enrolled 26 charts

Breast Neoplasms, Neoplasms

NCT03839823 2024-10-09

RIGHT Choice

222 enrolled 17 charts

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

NCT03321981 2024-03-07

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

105 enrolled 23 charts

Lethal Congenital Contracture Syndrome 2

NCT03481998 2023-11-21

A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Phase 1/2 Completed

104 enrolled

Breast Neoplasms

NCT02894398 2023-03-13

INGE-B

388 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02753686 2023-02-15

Treat ER+ight

440 enrolled

Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

221 enrolled 21 charts

Breast Neoplasms

NCT02441946 2020-06-17

neoMONARCH

224 enrolled 20 charts

Breast Neoplasms

NCT00295620 2019-10-02

SALSA

3,484 enrolled 18 charts

Breast Neoplasms

NCT02093351 2019-10-02

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Phase 1 Completed

79 enrolled 35 charts

Tumor-Agnostic

Neoplasms

NCT01597193 2019-05-08

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Phase 1 Completed

101 enrolled 33 charts

Breast Neoplasms

NCT00728949 2018-06-06

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

93 enrolled 14 charts

Breast Neoplasms

NCT01155089 2018-01-23

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions

Phase NA Completed

32 enrolled

Breast Neoplasms

NCT01155102 2018-01-23

Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions

Phase NA Completed

31 enrolled

Breast Neoplasms

NCT00248170 2016-04-19

FACE

4,172 enrolled 7 charts

Breast Neoplasms

NCT00081510 2015-04-15

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)

110 enrolled

Breast Neoplasms

NCT00077025 2014-07-16

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

174 enrolled

Breast Neoplasms

NCT00022672 2013-06-13

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

208 enrolled 20 charts

Breast Neoplasms

NCT00562458 2013-02-05

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

200 enrolled

Advanced Breast Cancer

NCT00544986 2013-01-30

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

Breast Neoplasms

NCT00537771 2013-01-25

HEART

384 enrolled 9 charts

Breast Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

197 enrolled 23 charts

Breast Neoplasms, Neoplasms

NCT00259090 2012-08-16

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

120 enrolled 10 charts

Breast Neoplasms

NCT00256698 2012-08-01

FACT

514 enrolled 13 charts

Breast Neoplasms, Neoplasms, Recurrence

NCT00660244 2012-06-06

Breast Cancer Tumor Care Observational Programme

150 enrolled

Arthralgia

NCT00323479 2012-04-06

Arthralgia During Anastrozole Therapy for Breast Cancer

114 enrolled 11 charts

Breast Neoplasms, Joint Diseases

NCT00143390 2012-01-25

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

298 enrolled 13 charts

Breast Neoplasms

NCT00944918 2011-08-29

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

25 enrolled

Breast Neoplasms

NCT00082277 2011-01-26

SABRE

237 enrolled

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00327769 2011-01-25

Faslodex Advanced Breast Cancer Local Chinese Study

234 enrolled

Advanced Breast Cancer

NCT00235937 2011-01-21

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

45 enrolled

Breast Neoplasms

NCT00357110 2010-12-21

@FAME

13 enrolled 7 charts

Breast Neoplasms, Neoplasms

NCT00232661 2010-02-03

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

452 enrolled

Breast Neoplasms

NCT00287534 2009-06-09

ARNO-95

1,059 enrolled

Breast Neoplasms

NCT00784862 2009-05-15

ATAC - Pharmacokinetics (PK) Sub-Protocol

9,358 enrolled

Breast Neoplasms

NCT00286117 2009-05-01

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

448 enrolled

Breast Neoplasms

NCT00300508 2009-05-01

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

856 enrolled

Breast Neoplasms

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

308 enrolled

Quality of Life

NCT00814125 2009-05-01

ATAC - Endometrial Sub-Protocol

285 enrolled

Breast Neoplasms

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

308 enrolled

Bone Density

NCT00255463 2009-04-23

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

185 enrolled

Breast Neoplasms

NCT00635713 2009-04-10

Second Line Breast Cancer Trial

588 enrolled